Literature DB >> 34341837

Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy. In regard to Vojtíšek et al.

Cem Onal1,2, Guler Yavas3, Cagdas Yavas3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34341837     DOI： 10.1007/s00066-021-01819-9

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  6 in total

1.  Treatment outcomes of patients with cervical cancer with complete metabolic responses after definitive chemoradiotherapy.

Authors:  Cem Onal; Mehmet Reyhan; Ozan C Guler; Ali Fuat Yapar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

2.  The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer.

Authors:  Alexander B Olawaiye; Thomas P Baker; M Kay Washington; David G Mutch
Journal:  CA Cancer J Clin       Date:  2021-03-30       Impact factor: 508.702

3.  Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.

Authors:  P G Rose; B N Bundy; E B Watkins; J T Thigpen; G Deppe; M A Maiman; D L Clarke-Pearson; S Insalaco
Journal:  N Engl J Med       Date:  1999-04-15       Impact factor: 91.245

Review 4.  Revised FIGO staging for carcinoma of the cervix uteri.

Authors:  Neerja Bhatla; Jonathan S Berek; Mauricio Cuello Fredes; Lynette A Denny; Seija Grenman; Kanishka Karunaratne; Sean T Kehoe; Ikuo Konishi; Alexander B Olawaiye; Jaime Prat; Rengaswamy Sankaranarayanan; James Brierley; David Mutch; Denis Querleu; David Cibula; Michael Quinn; Hennie Botha; Lax Sigurd; Laurel Rice; Hee-Sug Ryu; Hextan Ngan; Johanna Mäenpää; Andri Andrijono; Gatot Purwoto; Amita Maheshwari; Uttam D Bafna; Marie Plante; Jayashree Natarajan
Journal:  Int J Gynaecol Obstet       Date:  2019-01-17       Impact factor: 3.561

5.  Patterns of treatment failure following radiotherapy with combination chemotherapy for patients with high-risk stage IIB cervical carcinoma.

Authors:  Tchan-Kyu Park; Ja-Young Kwon; Sang-Wun Kim; Sung-Hoon Kim; Soo-Nyung Kim; Gwi Eon Kim
Journal:  Int J Clin Oncol       Date:  2004-04       Impact factor: 3.402

6.  Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy.

Authors:  Radovan Vojtíšek; Jan Baxa; Petra Kovářová; Amira Almortaza; Petr Hošek; Emília Sukovská; Radek Tupý; Jiří Ferda; Jindřich Fínek
Journal:  Strahlenther Onkol       Date:  2021-01-25       Impact factor: 3.621
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.